Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005849
Filing Date
2025-02-27
Accepted
2025-02-27 16:25:08
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 form4-02272025_040201.html 4  
1 form4-02272025_040201.xml 4 3610
  Complete submission text file 0001415889-25-005849.txt   5469
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 25679355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)